Results 211 to 220 of about 89,126 (347)

Acute effect of proprotein convertase subtilisin/kexin type 9 inhibitor on oxidized low-density lipoprotein and lipid profile in patients at cardiovascular risk. [PDF]

J Clin Biochem Nutr, 2023
Li Y, Sun M, Li R, Dou M, Dong H, Xue L, Sun G.   +6 more
europepmc   +1 more source

GLP‐1 Receptor Agonists in Metabolic Dysfunction‐Associated Steatotic Liver Disease: Bridging Hepatic and Cardiovascular Outcomes

Chronic Diseases and Translational Medicine, EarlyView.
Endogenous GLP‐1 and exogenous GLP‐1 RAs activate GLP‐1R‐expressing vagal afferents in the portal vein, projecting to the nucleus tractus solitarius (NTS). This input engages brainstem–hypothalamic circuits that regulate metabolic homeostasis. Hypothalamic efferent vagal output to the liver suppresses lipogenesis, enhances triglyceride export, and ...
Gabriel Amorim Moreira Alves, Masatoki Teranishi, Rajendranandini Majumdar, Fazal Khan, Mohan Dodeja, Ana Claudia Teixeira de Castro Gonçalves Ortega, Marco Acerboni, Arosh S. Perera Molligoda Arachchige, Frank James   +8 more
wiley   +1 more source

Reduced Uptake of Oxidized Low-Density Lipoprotein by Macrophages Using Multiple Aptamer Combinations. [PDF]

ACS Appl Bio Mater
Khongwichit S, Swangphon P, Nualla-Ong A, Prompat N, Amatatongchai M, Lieberzeit PA, Chunta S.   +6 more
europepmc   +1 more source

[Retracted] Astragaloside IV inhibits oxidized low‑density lipoprotein‑induced endothelial damage via upregulation of miR‑140‑3p. [PDF]

Int J Mol Med, 2023
Qian W, Qian Q, Cai X, Han R, Yang W, Zhang X, Zhao H, Zhu R.   +7 more
europepmc   +1 more source

ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages

, 2018
Andrés Laguna-Fernández, Antonio Checa, Miguel Carracedo, Gonzalo Artiach, Marcelo H. Petri, Roland Baumgartner, María J. Forteza, Xintong Jiang, Teodora Andonova, Mary E. Walker, Jesmond Dalli, Hildur Arnardottir, Anton Gisterå, Silke Thul, Craig E. Wheelock, Gabrielle Paulsson‐Berne, Daniel F.J. Ketelhuth, Göran K. Hansson, Magnus Bäck   +18 more
openalex   +2 more sources

BMP4 is increased in the aortas of diabetic ApoE knockout mice and enhances uptake of oxidized low density lipoprotein into peritoneal macrophages [PDF]

, 2013
Mitsuhisa Koga, Atsushi Yamauchi, Yuki Kanaoka, Ryusuke Jige, Anna Tsukamoto, Nao Teshima, Tsuyoshi Nishioku, Yasufumi Kataoka   +7 more
openalex   +1 more source

Uncovering Coenzyme Q10‐Related Genetic Determinants of Statin‐Associated Muscle Symptoms: Evidence from the UK Biobank and the All of Us Research Program

Clinical Pharmacology &Therapeutics, EarlyView.
Statin‐associated muscle symptoms (SAMS) are frequent adverse effects of statin therapy and have been hypothesized to result from impaired coenzyme Q10 (CoQ10) biosynthesis. Although genetic determinants of CoQ10 levels have been reported, genome‐wide association studies (GWASs) conducted specifically in statin users are lacking. Moreover, direct CoQ10
Da Hoon Lee, Yoon‐A Park, Yubin Song, Ji‐Min Han, Kyung Hee Choi, Myeong Gyu Kim, Hye Sun Gwak   +6 more
wiley   +1 more source

Oxidized Low-Density Lipoprotein as a Potential Target for Enhancing Immune Checkpoint Inhibitor Therapy in Microsatellite-Stable Colorectal Cancer. [PDF]

Antioxidants (Basel)
Zhang X, Ye X, Jin H.
europepmc   +1 more source

Limited Association between Antibodies to Oxidized Low-Density Lipoprotein and Vascular Affection in Patients with Established Systemic Lupus Erythematosus. [PDF]

Int J Mol Sci, 2023
Wirestam L, Jönsson F, Enocsson H, Svensson C, Weiner M, Wetterö J, Zachrisson H, Eriksson P, Sjöwall C.   +8 more
europepmc   +1 more source

Gemfibrozil decreases autoantibodies against oxidized low‐density lipoprotein in men with combined hyperlipidaemia [PDF]

, 1998
Hoogerbrugge, Kerkhofs, Jansen
openalex   +1 more source